An Evaluation of the Impact of REMS on Spontaneous Reporting for Marketed Products

被引:0
|
作者
Jain, Reema [1 ]
机构
[1] Johns Hopkins Univ, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
431
引用
收藏
页码:S183 / S183
页数:1
相关论文
共 50 条
  • [21] The impact of regulation changes in the spontaneous reporting system for vaccines on reporting trends and signal detection in Japan
    Miyazaki, Makoto
    Sakai, Takamasa
    Obara, Taku
    Mano, Nariyasu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (08) : 1091 - 1100
  • [22] Ochratoxin A in Italian marketed cocoa products
    Tafuri, A
    Ferracane, R
    Ritieni, A
    FOOD CHEMISTRY, 2004, 88 (04) : 487 - 494
  • [23] Evaluation of lung toxicity with bevacizumab using the spontaneous reporting database
    Yuko Kanbayashi
    Mayako Uchida
    Misui Kashiwagi
    Hitomi Akiba
    Tadashi Shimizu
    Scientific Reports, 12
  • [24] Evaluation of lung toxicity with bevacizumab using the spontaneous reporting database
    Kanbayashi, Yuko
    Uchida, Mayako
    Kashiwagi, Misui
    Akiba, Hitomi
    Shimizu, Tadashi
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [25] Topical Bioequivalence: Evaluation of Hydrocortisone Acetate, Betamethasone Valerate and Mupirocin Marketed Brazilian Products
    Cavalcanti, Isabelle M. F. S. D.
    Chagas, Stephanye C. C.
    Sousa, Giovana D.
    Barbosa, Irla C. F.
    Santana, Davi P.
    Leal, Leila B.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2019, 38 (06): : 1122 - 1129
  • [26] REVIEW OF MARKETED MEDICINAL PRODUCTS IN ITALY
    POGGIOLINI, D
    AGENTS AND ACTIONS, 1978, 8 (04): : 418 - 419
  • [27] Spontaneous Reporting of Adverse Events Due to Herbal Products in Pharmacovigilance Programme of India
    Kalaiselvan, V.
    Thota, P.
    Saurabh, A.
    Kumar, R.
    Singh, A.
    DRUG SAFETY, 2014, 37 (10) : 840 - 840
  • [29] A Multi-modal Approach to Evaluate the Impact of Risk Evaluation and Mitigation Strategy (REMS) Programs
    Ameet Sarpatwari
    Mayookha Mitra-Majumdar
    Katsiaryna Bykov
    Jerry Avorn
    Steven Woloshin
    Gita A. Toyserkani
    Cynthia LaCivita
    Claudia Manzo
    Esther H. Zhou
    Ellen Pinnow
    Gerald J. Dal Pan
    Joshua J. Gagne
    Krista F. Huybrechts
    William B. Feldman
    Kristyn Chin
    Aaron S. Kesselheim
    Drug Safety, 2021, 44 : 743 - 751
  • [30] Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France
    Sibylle de Germay
    Allison Singier
    Francesco Salvo
    Antoine Pariente
    Drug Safety, 2023, 46 : 1381 - 1389